Osteoglycin as regenerative agent for lung tissue

Reinoud Gosens; Luke van der Koog; Adriana Pieternella Nagelkerke; Hendrik Willem Frijlink

Osteoglycin as regenerative agent for lung tissue

Reinoud Gosens (Inventor), Luke van der Koog (Inventor), Adriana Pieternella Nagelkerke (Inventor), Hendrik Willem Frijlink (Inventor)

Research output: Patent

3 Downloads (Pure)

Abstract

The invention relates to the field of medicine and tissue engineering, more specifically to means and methods to boost the repair of epithelial cells, such as damaged lung tissue as is observed in diseases with defective lung repair including as chronic obstructive pulmonary disease (COPD). Provided is osteoglycin (OGN; Osteoinductive factor, mimecan), or a functional fragment thereof, for use as an agent to promote the regeneration of epithelial cells or epithelial tissue.

Original language	English
Patent number	WO2024258278
Priority date	13/06/2023
Filing date	17/05/2024
Publication status	Published - 19-Dec-2024

Access to Document

WO2024258278_A1Final publisher's version, 5.74 MB

Handle.net

Persistent link

Cite this

@misc{32d4f94e7f01444d982cee68d61d8489,

title = "Osteoglycin as regenerative agent for lung tissue",

abstract = "The invention relates to the field of medicine and tissue engineering, more specifically to means and methods to boost the repair of epithelial cells, such as damaged lung tissue as is observed in diseases with defective lung repair including as chronic obstructive pulmonary disease (COPD). Provided is osteoglycin (OGN; Osteoinductive factor, mimecan), or a functional fragment thereof, for use as an agent to promote the regeneration of epithelial cells or epithelial tissue.",

author = "Reinoud Gosens and {van der Koog}, Luke and Nagelkerke, {Adriana Pieternella} and Frijlink, {Hendrik Willem}",

year = "2024",

month = dec,

day = "19",

language = "English",

type = "Patent",

note = "WO2024258278",

}

TY - PAT

T1 - Osteoglycin as regenerative agent for lung tissue

AU - Gosens, Reinoud

AU - van der Koog, Luke

AU - Nagelkerke, Adriana Pieternella

AU - Frijlink, Hendrik Willem

PY - 2024/12/19

Y1 - 2024/12/19

N2 - The invention relates to the field of medicine and tissue engineering, more specifically to means and methods to boost the repair of epithelial cells, such as damaged lung tissue as is observed in diseases with defective lung repair including as chronic obstructive pulmonary disease (COPD). Provided is osteoglycin (OGN; Osteoinductive factor, mimecan), or a functional fragment thereof, for use as an agent to promote the regeneration of epithelial cells or epithelial tissue.

AB - The invention relates to the field of medicine and tissue engineering, more specifically to means and methods to boost the repair of epithelial cells, such as damaged lung tissue as is observed in diseases with defective lung repair including as chronic obstructive pulmonary disease (COPD). Provided is osteoglycin (OGN; Osteoinductive factor, mimecan), or a functional fragment thereof, for use as an agent to promote the regeneration of epithelial cells or epithelial tissue.

M3 - Patent

M1 - WO2024258278

Y2 - 2024/05/17

ER -

Osteoglycin as regenerative agent for lung tissue

Abstract

Access to Document

Handle.net

Fingerprint

Cite this